
### [NCIT:C3172](http://purl.obolibrary.org/obo/NCIT_C3172)
**Label:** Myeloid Leukemia

**Subclasses:** [NCIT:C9129](http://purl.obolibrary.org/obo/NCIT_C9129) (Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia), [NCIT:C9128](http://purl.obolibrary.org/obo/NCIT_C9128) (Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia), [NCIT:C82423](http://purl.obolibrary.org/obo/NCIT_C82423) (Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214), [NCIT:C125715](http://purl.obolibrary.org/obo/NCIT_C125715) (Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes), [NCIT:C82426](http://purl.obolibrary.org/obo/NCIT_C82426) (Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM), [NCIT:C82427](http://purl.obolibrary.org/obo/NCIT_C82427) (Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.3); RBM15-MKL1), [NCIT:C7463](http://purl.obolibrary.org/obo/NCIT_C7463) (Acute Myelomonocytic Leukemia), [NCIT:C122725](http://purl.obolibrary.org/obo/NCIT_C122725) (Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q), [NCIT:C122726](http://purl.obolibrary.org/obo/NCIT_C122726) (Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7), [NCIT:C122687](http://purl.obolibrary.org/obo/NCIT_C122687) (Cytogenetically Normal Acute Myeloid Leukemia), [NCIT:C122688](http://purl.obolibrary.org/obo/NCIT_C122688) (Core Binding Factor Acute Myeloid Leukemia), [NCIT:C134319](http://purl.obolibrary.org/obo/NCIT_C134319) (Refractory Acute Myeloid Leukemia), [NCIT:C9019](http://purl.obolibrary.org/obo/NCIT_C9019) (Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11), [NCIT:C9018](http://purl.obolibrary.org/obo/NCIT_C9018) (Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11), [NCIT:C9020](http://purl.obolibrary.org/obo/NCIT_C9020) (Acute Myelomonocytic Leukemia with Abnormal Eosinophils), [NCIT:C38377](http://purl.obolibrary.org/obo/NCIT_C38377) (Acute Myeloid Leukemia with t(17;17)(q21;q21)), [NCIT:C9381](http://purl.obolibrary.org/obo/NCIT_C9381) (Childhood Acute Myeloid Leukemia with Maturation), [NCIT:C9380](http://purl.obolibrary.org/obo/NCIT_C9380) (Adult Acute Myeloid Leukemia without Maturation), [NCIT:C122690](http://purl.obolibrary.org/obo/NCIT_C122690) (Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6), [NCIT:C7968](http://purl.obolibrary.org/obo/NCIT_C7968) (Childhood Acute Promyelocytic Leukemia with PML-RARA), [NCIT:C7964](http://purl.obolibrary.org/obo/NCIT_C7964) (Adult Acute Basophilic Leukemia), [NCIT:C7600](http://purl.obolibrary.org/obo/NCIT_C7600) (Acute Myeloid Leukemia with Myelodysplasia-Related Changes), [NCIT:C3249](http://purl.obolibrary.org/obo/NCIT_C3249) (Acute Myeloid Leukemia without Maturation), [NCIT:C7965](http://purl.obolibrary.org/obo/NCIT_C7965) (Adult Acute Megakaryoblastic Leukemia), [NCIT:C7962](http://purl.obolibrary.org/obo/NCIT_C7962) (Adult Acute Myelomonocytic Leukemia), [NCIT:C7961](http://purl.obolibrary.org/obo/NCIT_C7961) (Adult Acute Myeloid Leukemia with Maturation), [NCIT:C9068](http://purl.obolibrary.org/obo/NCIT_C9068) (Recurrent Childhood Acute Myeloid Leukemia), [NCIT:C82403](http://purl.obolibrary.org/obo/NCIT_C82403) (Acute Myeloid Leukemia with t(9;11)(p22.3;q23.3); MLLT3-KMT2A), [NCIT:C122625](http://purl.obolibrary.org/obo/NCIT_C122625) (Childhood Acute Myeloid Leukemia Not Otherwise Specified), [NCIT:C8252](http://purl.obolibrary.org/obo/NCIT_C8252) (Therapy-Related Acute Myeloid Leukemia), [NCIT:C7320](http://purl.obolibrary.org/obo/NCIT_C7320) (Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C7171](http://purl.obolibrary.org/obo/NCIT_C7171) (Acute Monoblastic Leukemia), [NCIT:C68698](http://purl.obolibrary.org/obo/NCIT_C68698) (Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11), [NCIT:C68699](http://purl.obolibrary.org/obo/NCIT_C68699) (Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1), [NCIT:C68696](http://purl.obolibrary.org/obo/NCIT_C68696) (Adult Acute Myeloid Leukemia with t(9;11)(p22.3;q23.3); MLLT3-KMT2A), [NCIT:C68697](http://purl.obolibrary.org/obo/NCIT_C68697) (Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11), [NCIT:C9070](http://purl.obolibrary.org/obo/NCIT_C9070) (Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C6924](http://purl.obolibrary.org/obo/NCIT_C6924) (Acute Myeloid Leukemia with Variant MLL Translocations), [NCIT:C4344](http://purl.obolibrary.org/obo/NCIT_C4344) (Acute Panmyelosis with Myelofibrosis), [NCIT:C4861](http://purl.obolibrary.org/obo/NCIT_C4861) (Acute Monocytic Leukemia), [NCIT:C8304](http://purl.obolibrary.org/obo/NCIT_C8304) (Childhood Acute Myeloid Leukemia with Minimal Differentiation), [NCIT:C3250](http://purl.obolibrary.org/obo/NCIT_C3250) (Acute Myeloid Leukemia with Maturation), [NCIT:C7971](http://purl.obolibrary.org/obo/NCIT_C7971) (Childhood Acute Basophilic Leukemia), [NCIT:C8303](http://purl.obolibrary.org/obo/NCIT_C8303) (Adult Acute Myeloid Leukemia with Minimal Differentiation), [NCIT:C7970](http://purl.obolibrary.org/obo/NCIT_C7970) (Childhood Acute Myelomonocytic Leukemia), [NCIT:C7972](http://purl.obolibrary.org/obo/NCIT_C7972) (Childhood Acute Megakaryoblastic Leukemia), [NCIT:C7175](http://purl.obolibrary.org/obo/NCIT_C7175) (Acute Myeloid Leukemia with Recurrent Genetic Abnormalities), [NCIT:C42779](http://purl.obolibrary.org/obo/NCIT_C42779) (Acute Myelomonocytic Leukemia without Abnormal Eosinophils), [NCIT:C8263](http://purl.obolibrary.org/obo/NCIT_C8263) (Adult Acute Monocytic Leukemia), [NCIT:C9110](http://purl.obolibrary.org/obo/NCIT_C9110) (Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C25765](http://purl.obolibrary.org/obo/NCIT_C25765) (Secondary Acute Myeloid Leukemia), [NCIT:C129786](http://purl.obolibrary.org/obo/NCIT_C129786) (Acute Myeloid Leukemia with Mutated RUNX1), [NCIT:C129785](http://purl.obolibrary.org/obo/NCIT_C129785) (Acute Myeloid Leukemia with BCR-ABL1), [NCIT:C7303](http://purl.obolibrary.org/obo/NCIT_C7303) (Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C4037](http://purl.obolibrary.org/obo/NCIT_C4037) (Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome), [NCIT:C7940](http://purl.obolibrary.org/obo/NCIT_C7940) (Childhood Acute Monoblastic and Monocytic Leukemia), [NCIT:C3182](http://purl.obolibrary.org/obo/NCIT_C3182) (Acute Promyelocytic Leukemia with PML-RARA), [NCIT:C9288](http://purl.obolibrary.org/obo/NCIT_C9288) (Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1), [NCIT:C9289](http://purl.obolibrary.org/obo/NCIT_C9289) (Acute Myeloid Leukemia with Multilineage Dysplasia), [NCIT:C9287](http://purl.obolibrary.org/obo/NCIT_C9287) (Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11), [NCIT:C7319](http://purl.obolibrary.org/obo/NCIT_C7319) (Adult Acute Monoblastic and Monocytic Leukemia), [NCIT:C7318](http://purl.obolibrary.org/obo/NCIT_C7318) (Acute Monoblastic and Monocytic Leukemia), [NCIT:C8923](http://purl.obolibrary.org/obo/NCIT_C8923) (Acute Erythroid Leukemia), [NCIT:C27753](http://purl.obolibrary.org/obo/NCIT_C27753) (Acute Myeloid Leukemia Not Otherwise Specified), [NCIT:C7882](http://purl.obolibrary.org/obo/NCIT_C7882) (Recurrent Adult Acute Myeloid Leukemia), [NCIT:C7885](http://purl.obolibrary.org/obo/NCIT_C7885) (Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C27755](http://purl.obolibrary.org/obo/NCIT_C27755) (Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia), [NCIT:C27754](http://purl.obolibrary.org/obo/NCIT_C27754) (Alkylating Agent-Related Acute Myeloid Leukemia), [NCIT:C3164](http://purl.obolibrary.org/obo/NCIT_C3164) (Acute Basophilic Leukemia), [NCIT:C27757](http://purl.obolibrary.org/obo/NCIT_C27757) (Microgranular Acute Promyelocytic Leukemia), [NCIT:C27756](http://purl.obolibrary.org/obo/NCIT_C27756) (Typical Acute Promyelocytic Leukemia), [NCIT:C8460](http://purl.obolibrary.org/obo/NCIT_C8460) (Acute Myeloid Leukemia with Minimal Differentiation), [NCIT:C9153](http://purl.obolibrary.org/obo/NCIT_C9153) (Adult Acute Erythroid Leukemia), [NCIT:C132101](http://purl.obolibrary.org/obo/NCIT_C132101) (Acute Myeloid Leukemia with t(10;11)(p12;q23); MLL-MLLT10), [NCIT:C3173](http://purl.obolibrary.org/obo/NCIT_C3173) (Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C122716](http://purl.obolibrary.org/obo/NCIT_C122716) (Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM), [NCIT:C82433](http://purl.obolibrary.org/obo/NCIT_C82433) (Acute Myeloid Leukemia with Mutated CEBPA), [NCIT:C122717](http://purl.obolibrary.org/obo/NCIT_C122717) (Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM), [NCIT:C3171](http://purl.obolibrary.org/obo/NCIT_C3171) (Acute Myeloid Leukemia), [NCIT:C9158](http://purl.obolibrary.org/obo/NCIT_C9158) (Childhood Acute Myeloid Leukemia without Maturation), [NCIT:C3170](http://purl.obolibrary.org/obo/NCIT_C3170) (Acute Megakaryoblastic Leukemia), [NCIT:C5630](http://purl.obolibrary.org/obo/NCIT_C5630) (Aleukemic Monocytic Leukemia Cutis), [NCIT:C9156](http://purl.obolibrary.org/obo/NCIT_C9156) (Adult Acute Monoblastic Leukemia), [NCIT:C3177](http://purl.obolibrary.org/obo/NCIT_C3177) (Philadelphia-Positive Myelogenous Leukemia), [NCIT:C3176](http://purl.obolibrary.org/obo/NCIT_C3176) (Philadelphia-Negative Myelogenous Leukemia), [NCIT:C9154](http://purl.obolibrary.org/obo/NCIT_C9154) (Adult Acute Myeloid Leukemia), [NCIT:C3175](http://purl.obolibrary.org/obo/NCIT_C3175) (Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C3174](http://purl.obolibrary.org/obo/NCIT_C3174) (Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C9155](http://purl.obolibrary.org/obo/NCIT_C9155) (Adult Acute Promyelocytic Leukemia with PML-RARA), [NCIT:C9163](http://purl.obolibrary.org/obo/NCIT_C9163) (Childhood Acute Monocytic Leukemia), [NCIT:C9164](http://purl.obolibrary.org/obo/NCIT_C9164) (Childhood Acute Erythroid Leukemia), [NCIT:C68700](http://purl.obolibrary.org/obo/NCIT_C68700) (Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities), [NCIT:C9162](http://purl.obolibrary.org/obo/NCIT_C9162) (Childhood Acute Monoblastic Leukemia), [NCIT:C36058](http://purl.obolibrary.org/obo/NCIT_C36058) (Acute Myeloid Leukemia with t(11;17)(q13;q21)), [NCIT:C9160](http://purl.obolibrary.org/obo/NCIT_C9160) (Childhood Acute Myeloid Leukemia), [NCIT:C36057](http://purl.obolibrary.org/obo/NCIT_C36057) (Acute Myeloid Leukemia with t(5;17)(q35;q21)), [NCIT:C36056](http://purl.obolibrary.org/obo/NCIT_C36056) (Acute Myeloid Leukemia with t(11;17)(q23;q21)), [NCIT:C82430](http://purl.obolibrary.org/obo/NCIT_C82430) (Acute Myeloid Leukemia with Gene Mutations), [NCIT:C82431](http://purl.obolibrary.org/obo/NCIT_C82431) (Acute Myeloid Leukemia with Mutated NPM1), [NCIT:C36055](http://purl.obolibrary.org/obo/NCIT_C36055) (Acute Myeloid Leukemia with a Variant RARA Translocation), 

**Class expressions from DL-Learner:**

- Thing 52.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39821](http://purl.obolibrary.org/obo/NCIT_C39821) (Infiltrating Bladder Lymphoepithelioma-Like Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39820](http://purl.obolibrary.org/obo/NCIT_C39820) (Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39819](http://purl.obolibrary.org/obo/NCIT_C39819) (Infiltrating Bladder Urothelial Carcinoma, Nested Variant))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39818](http://purl.obolibrary.org/obo/NCIT_C39818) (Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39817](http://purl.obolibrary.org/obo/NCIT_C39817) (Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39815](http://purl.obolibrary.org/obo/NCIT_C39815) (Cellular Congenital Mesoblastic Nephroma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39814](http://purl.obolibrary.org/obo/NCIT_C39814) (Classic Congenital Mesoblastic Nephroma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39813](http://purl.obolibrary.org/obo/NCIT_C39813) (SMARCB1 Gene Inactivation))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39812](http://purl.obolibrary.org/obo/NCIT_C39812) (Metanephric Adenofibroma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39811](http://purl.obolibrary.org/obo/NCIT_C39811) (t(5;11)(q35;q13)))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39810](http://purl.obolibrary.org/obo/NCIT_C39810) (Type 2 Renal Papillary Adenoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39809](http://purl.obolibrary.org/obo/NCIT_C39809) (Type 1 Renal Papillary Adenoma))) 40.36%


